Biotech · Private company · La Jolla, CA, US
Neurano Bioscience
Track this companyFree. Adds Neurano Bioscience to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorderFiscal year 2025 · $810.9KNIH RePORTER 5R44DA050393-04 · fetched Nov 12, 2026
- Evaluation of the therapeutic potential of exclusive antagonists of extrasynaptic NMDA receptors for the treatment of opioid use disorderFiscal year 2024 · $837.9KNIH RePORTER 5R44DA050393-03 · fetched Nov 12, 2026